Robert W. Baird Boosts Mettler-Toledo International, Inc. (MTD) Price Target to $675.00

Mettler-Toledo International, Inc. (NYSE:MTD) had its price target lifted by Robert W. Baird from $605.00 to $675.00 in a report released on Friday. Robert W. Baird currently has a neutral rating on the medical instruments supplier’s stock.

MTD has been the topic of a number of other research reports. Bank of America Corporation boosted their target price on shares of Mettler-Toledo International from $640.00 to $710.00 and gave the stock a buy rating in a research report on Monday, October 9th. Zacks Investment Research lowered shares of Mettler-Toledo International from a buy rating to a hold rating in a research report on Tuesday, September 26th. Jefferies Group LLC reaffirmed a hold rating and set a $550.00 target price on shares of Mettler-Toledo International in a research report on Thursday, July 27th. BidaskClub raised shares of Mettler-Toledo International from a buy rating to a strong-buy rating in a research report on Wednesday, July 12th. Finally, Goldman Sachs Group, Inc. (The) reaffirmed a buy rating and set a $690.00 target price on shares of Mettler-Toledo International in a research report on Tuesday, September 26th. Five research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. The stock has a consensus rating of Buy and an average target price of $621.57.

Shares of Mettler-Toledo International (MTD) traded down $11.30 during mid-day trading on Friday, reaching $634.70. The company’s stock had a trading volume of 131,176 shares, compared to its average volume of 116,728. Mettler-Toledo International has a 1-year low of $407.86 and a 1-year high of $694.48. The company has a market capitalization of $16,524.11, a P/E ratio of 38.22, a P/E/G ratio of 2.95 and a beta of 1.13. The company has a debt-to-equity ratio of 2.05, a quick ratio of 1.11 and a current ratio of 1.51.

Mettler-Toledo International (NYSE:MTD) last released its quarterly earnings results on Thursday, November 2nd. The medical instruments supplier reported $4.36 EPS for the quarter, beating the Zacks’ consensus estimate of $4.32 by $0.04. Mettler-Toledo International had a net margin of 16.44% and a return on equity of 96.81%. The company had revenue of $698.80 million for the quarter, compared to analyst estimates of $685.56 million. During the same quarter last year, the firm posted $3.89 earnings per share. The company’s quarterly revenue was up 7.4% compared to the same quarter last year. research analysts predict that Mettler-Toledo International will post 17.45 EPS for the current year.

TRADEMARK VIOLATION NOTICE: This story was originally posted by Community Financial News and is the sole property of of Community Financial News. If you are accessing this story on another domain, it was illegally copied and reposted in violation of U.S. and international trademark & copyright law. The correct version of this story can be read at https://www.com-unik.info/2017/11/06/robert-w-baird-boosts-mettler-toledo-international-inc-mtd-price-target-to-675-00.html.

In other Mettler-Toledo International news, insider Waldemar Rauch sold 2,203 shares of Mettler-Toledo International stock in a transaction on Monday, August 28th. The shares were sold at an average price of $594.27, for a total transaction of $1,309,176.81. Following the sale, the insider now owns 7,771 shares in the company, valued at $4,618,072.17. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Thomas Caratsch sold 3,000 shares of Mettler-Toledo International stock in a transaction on Monday, August 14th. The stock was sold at an average price of $582.03, for a total transaction of $1,746,090.00. Following the sale, the insider now owns 2,270 shares in the company, valued at approximately $1,321,208.10. The disclosure for this sale can be found here. Insiders have sold 21,181 shares of company stock worth $12,586,582 in the last quarter. Corporate insiders own 5.20% of the company’s stock.

A number of institutional investors and hedge funds have recently bought and sold shares of the business. First Personal Financial Services boosted its stake in shares of Mettler-Toledo International by 2.8% in the 2nd quarter. First Personal Financial Services now owns 186 shares of the medical instruments supplier’s stock valued at $109,000 after purchasing an additional 5 shares in the last quarter. Sun Life Financial INC boosted its stake in shares of Mettler-Toledo International by 2,585.7% in the 2nd quarter. Sun Life Financial INC now owns 188 shares of the medical instruments supplier’s stock valued at $111,000 after purchasing an additional 181 shares in the last quarter. Acrospire Investment Management LLC acquired a new stake in shares of Mettler-Toledo International in the 2nd quarter valued at $118,000. CAPROCK Group Inc. acquired a new stake in shares of Mettler-Toledo International in the 2nd quarter valued at $205,000. Finally, Personal Capital Advisors Corp acquired a new stake in shares of Mettler-Toledo International in the 2nd quarter valued at $206,000. Hedge funds and other institutional investors own 93.16% of the company’s stock.

About Mettler-Toledo International

Mettler-Toledo International Inc is a supplier of precision instruments and services. The Company operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations and Other. The Company manufactures weighing instruments for use in laboratory, industrial, packaging, logistics and food retailing applications.

Analyst Recommendations for Mettler-Toledo International (NYSE:MTD)

What are top analysts saying about Mettler-Toledo International Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Mettler-Toledo International Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit